Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1515/cclm-2020-1412 http://scihub22266oqcxt.onion/10.1515/cclm-2020-1412 33027042!ä!33027042 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Chem+Lab+Med 2020 ; 58 (12): 1993-2000 Nephropedia Template TP {{tp|p=33027042|t=2020. IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection |pdf=|usr=}}{{33027042}} gab.com Text IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection JO: Clin Chem Lab Med http://www.kidney.de/pget.php?&tw=1&pmid=33027042 #FOAvip The diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection globally has relied extensively on molecular testing, contributing vitally to case identification, isolation, contact tracing, and rationalization of infection control measures during the coronavirus disease 2019 (COVID-19) pandemic. Clinical laboratories have thus needed to verify newly developed molecular tests and increase testing capacity at an unprecedented rate. As the COVID-19 pandemic continues to pose a global health threat, laboratories continue to encounter challenges in the selection, verification, and interpretation of these tests. This document by the International Federation for Clinical Chemistry and Laboratory Medicine (IFCC) Task Force on COVID-19 provides interim guidance on: (A) clinical indications and target populations, (B) assay selection, (C) assay verification, and (D) test interpretation and limitations for molecular testing of SARS-CoV-2 infection. These evidence-based recommendations will provide practical guidance to clinical laboratories worldwide and highlight the continued importance of laboratory medicine in our collective pandemic response. Twit Text FOAVip IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection ????Clin Chem Lab Med http://www.kidney.de/pget.php?&tw=1&pmid=33027042 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33027042 #FOAvip English Wikipedia <ref>{{Cite pmid|33027042}}</ref> IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection #MMPMID33027042 Bohn MK; Mancini N; Loh TP; Wang CB; Grimmler M; Gramegna M; Yuen KY; Mueller R; Koch D; Sethi S; Rawlinson WD; Clementi M; Erasmus R; Leportier M; Kwon GC; Menezes ME; Patru MM; Singh K; Ferrari M; Najjar O; Horvath AR; Adeli K; Lippi G Clin Chem Lab Med 2020[Oct]; 58 (12): 1993-2000 PMID33027042show ga The diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection globally has relied extensively on molecular testing, contributing vitally to case identification, isolation, contact tracing, and rationalization of infection control measures during the coronavirus disease 2019 (COVID-19) pandemic. Clinical laboratories have thus needed to verify newly developed molecular tests and increase testing capacity at an unprecedented rate. As the COVID-19 pandemic continues to pose a global health threat, laboratories continue to encounter challenges in the selection, verification, and interpretation of these tests. This document by the International Federation for Clinical Chemistry and Laboratory Medicine (IFCC) Task Force on COVID-19 provides interim guidance on: (A) clinical indications and target populations, (B) assay selection, (C) assay verification, and (D) test interpretation and limitations for molecular testing of SARS-CoV-2 infection. These evidence-based recommendations will provide practical guidance to clinical laboratories worldwide and highlight the continued importance of laboratory medicine in our collective pandemic response. |*International Agencies[MESH] |*Molecular Diagnostic Techniques[MESH] |*Practice Guidelines as Topic[MESH] |Betacoronavirus/genetics/physiology[MESH] |COVID-19[MESH] |Coronavirus Infections/*diagnosis[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*diagnosis[MESH]IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection (epmc).pdf DeepDyve Pubget Overpricing